The invention relates to antibodies to MASP-2. In particular, the invention relates to MASP-2 antibodies capable of inhibiting the function of MASP-2. The invention also relates to methods of producing said antibodies, methods of inhibiting MASP-2 activity as well as to pharmaceutical compositions comprising the MASP-2 antibodies.